An elderly patient with a bronchoesophageal fistula secondary to tuberculosis and a 3-month history of cough and dysphagia worsening with deglutition was admitted to hospital. Radiological examination and CT of the thorax revealed mediastinal adenopathy. Bronchoscopy, esophagoscopy and esophagraphy confirmed the presence of a bronchoesophageal fistula. Histological examination of the esophagus and bronchial biopsy specimens revealed nonnecrotic granulomas, and the acid-fast bacilli tested positive for Mycobacterium tuberculosis in respiratory secretions. Antituberculous treatment was started after diagnosis of intrathoracic lymph node tuberculosis with bronchoesophageal fistulization. A month and a half after initiating treatment, paroxistic coughing during deglutition persisted. An esophagoscopy was performed, and the orifice was closed with a fibrin tissue. After 9 months of treatment, the patient was asymptomatic and in good health.

Keywords:
Bronchoesophageal fistulae, Tuberculosis, Intrathoracic adenopathy
1.
Spalding AR, Burney DP, Richie RE: Acquired benign bronchoesophageal fistulas in the adult. Ann Thorac Surg 1979;28:379–383.
2.
Risher WH, Arensman RM, Ochsner JL: Congenital bronchoesophageal fistula. Ann Thorac Surg 1990;49:500–505.
3.
Kim JH, Park KH, Sung SW, Rho JR: Bronchoesophageal fistulas in adult patients. Ann Thorac Surg 1995;60:151–155.
4.
Wigley FM, Murray HW, Mann RB, Saba GP, Kashima H, Mann JJ: Unusual manifestation of tuberculosis: TE fistula. Am J Med 1976;60:310–314.
5.
Sridhar KS, Barreras L, Saldana MJ, Manten H: Respiratory tract fistulae in recurrent aerodigestive cancers after chemotherapy. Cancer 1988;61:247–251.
6.
Porter JC, Friedland JS, Freedman AR: Tuberculous bronchoesophageal fistulae in patients infected with the human immunodeficiency virus: Three case reports and review. Clin Infect Dis 1994;19:954–957.
7.
Lucaya J, Sole S, Badosa J, Manzanares R: Bronchial perforation and bronchoesophageal fistulas: Tuberculous origin in children. Am J Radiol 1980;135:525–528.
8.
Bashi SA, Laajam MB, Joharjy IA, Abdullah AK: Tuberculous oesophagopulmonary communication: Effectiveness of antituberculous chemotherapy. A case report and review of literature. Digestion 1985;32:145–148.
9.
Shafer RW, Chirgwin KD, Glatt AE, Dahdouh A, Landesman SH, Suster B: HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS 1991;5:399–405.
10.
Lado Lado FL, Barrio Gómez E, Carballo Arceo E, Cabarcos Ortíz de Barrón A: Clinical presentation of tuberculosis and the degree of immunodeficiency in patients with HIV infection. Scand J Infect Dis 1999;31:387–391.
11.
Winterbauer RH, Belia N, Moores KD: A clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973;78:65–71.
12.
Pastores SM, Naidich DP, Aranda CP, McGuines G, Rom WN: Intrathoracic adenopathy associated with pulmonary tuberculosis in patients with human immunodeficiency virus infection. Chest 1993;103:1433–1437.
13.
Tuñez Bastida MV, Golpe Gómez AL, Paniagua López J: La enfermedad tuberculosa en el área sanitaria de Santiago durante el año 1995. Arch Bronconeumol 1997;33(suppl 1):S32.
14.
Dronda F, Fernández–Martin I, González-López A, Puente L: Delayed development of tuberculosis bronchoesophageal fistulas in a patient with AIDS necessitates endoscopic surgery. Clin Infect Dis 1995;21:1062–1063.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.